Replacing defective microglia can halt ALSP—a fatal neurodegenerative disease—in mice and humans, offering hope for broader brain therapies.

NMDPSM, a global nonprofit leader in cell therapy, and its collaborative research program, CIBMTR (Center for International ...

Organ transplantation saves over 48,000 lives each year in the United States. Across the country, 100,000 people are ...

Earlier diagnoses and advancements in treatment options are providing hope for patients with endometrial cancer like Yaca.

Years after signing up to be a bone marrow donor, this woman was finally matched with a transplant patient—and she couldn't believe who it was for.

Florida teacher with rare condition matches with 2 donors for bone marrow transplant News 6 hears from Jaymala Lalwani ORLANDO, Fla.

This is the first-in-human phase 1/2a trial of Treg and bone marrow transplantation in HLA-mismatched living donor kidney transplant recipients.

A local foreign-language teacher dealt with a debilitating condition that required blood transfusions for years before finally getting a life-saving transplant in Orlando. Now, she’s sharing her ...

Sanofi's riliprubart gets FDA orphan drug status for organ transplant rejection, unlocking key development perks.

(RTTNews) - The U.S. Food and Drug Administration has granted orphan drug designation to riliprubart for the investigational treatment of antibody-mediated rejection (AMR) in solid organ ...

Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney transplant recipients Riliprubart was also designated orphan ...